Misra, P. and Singh, S. (2019) Role of cytokines in combinatorial immunotherapeutics of non-small cell lung cancer through systems perspective. Cancer Medicine.

Text 112-1.Dr.Singh S. (Cancer Medicine) author version.pdf Restricted to Registered users only Download (739Kb) | Request a copy

Abstract

Lung cancer is the leading cause of deaths related to cancer and accounts for more than a million deaths per year. Various new strategies have been developed and adapted for treatment; still the survival for 5 years is just 16% in patients with non‐small cell lung cancer (NSCLC). Most of these strategies to combat NSCLC whether it is a drug molecule or immunotherapy/vaccine candidate require a big cost and time. Integration of computational modeling with systems biology has opened new avenues for understanding complex cancer biology. Resolving the complex interactions of various pathways and their crosstalk leading to oncogenic changes could identify new therapeutic targets with lesser cost and time. Herein, this review provides an overview of various aspects of NSCLC along with available strategies for its cure concluding with our insight into how systems approach could serve as a therapeutic intervention dissecting the immunologic parameters and cross talk between various pathways involved.

Item Type:	Article
Depositing User:	Mr. Rameshwar Nema
Date Deposited:	20 Feb 2020 07:08
Last Modified:	10 Feb 2021 07:52
URI:	http://nccs.sciencecentral.in/id/eprint/708

Actions (login required)

View Item